Home > Qtrly Results > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Quarterly Results Analysis [Dec2025]

MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

MEDICAMEN BIOTECH Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹47 Cr ₹47 Cr ₹43 Cr ₹30 Cr ₹45 Cr ₹45 Cr ₹43 Cr ₹47 Cr
Expenses ₹43 Cr ₹42 Cr ₹38 Cr ₹31 Cr ₹38 Cr ₹39 Cr ₹40 Cr ₹42 Cr
Operating Income ₹4 Cr ₹5 Cr ₹5 Cr ₹-2 Cr ₹7 Cr ₹5 Cr ₹3 Cr ₹6 Cr
Other Income ₹1 Cr ₹0 Cr ₹0 Cr ₹5 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹1 Cr
Interest ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹2 Cr
Depreciation ₹2 Cr ₹2 Cr ₹2 Cr ₹0 Cr ₹2 Cr ₹3 Cr ₹2 Cr ₹2 Cr
Profit Before Tax ₹2 Cr ₹3 Cr ₹2 Cr ₹2 Cr ₹4 Cr ₹2 Cr ₹2 Cr ₹3 Cr
Profit After Tax ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹3 Cr ₹1 Cr ₹1 Cr ₹2 Cr
EPS ₹1.61 ₹1.97 ₹1.59 ₹1.90 ₹2.73 ₹1.15 ₹1.06 ₹1.67
Industry Peers & Returns1W1M1Y
MEDICAMEN BIOTECH -6.2% -13.3% -26%
SUN PHARMACEUTICAL INDUSTRIES 1.5% 5.5% 0.5%
DIVIS LABORATORIES 2.3% 3.6% 7.8%
CIPLA -1.1% -2.2% -8.9%
TORRENT PHARMACEUTICALS -0.5% 5.3% 40.2%
DR REDDYS LABORATORIES 0.9% 5.2% 7%
MANKIND PHARMA -2.6% -5.6% -15%
ZYDUS LIFESCIENCES -1% 1.8% 0.1%
LUPIN -0% 2.5% 13.2%

MEDICAMEN BIOTECH Quarterly Revenues

Revenues
Q-o-Q

-0.56 %

Y-o-Y

3.91 %

Quarters Revenues % Change
Dec2025 ₹47 Cr
-0.56
Sep2025 ₹47 Cr
9.58
Jun2025 ₹43 Cr
45.36
Mar2025 ₹30 Cr
-34.40
Dec2024 ₹45 Cr
0.89
Sep2024 ₹45 Cr
3.94
Jun2024 ₹43 Cr
-9.03
Mar2024 ₹47 Cr -

MEDICAMEN BIOTECH Quarterly Operating Profit

Operating Profit
Q-o-Q

-15.15 %

Y-o-Y

-34.76 %

Quarters Operating Profit % Change
Dec2025 ₹4 Cr
-15.15
Sep2025 ₹5 Cr
11.70
Jun2025 ₹5 Cr
Positive
Mar2025 ₹-2 Cr
Negative
Dec2024 ₹7 Cr
26.17
Sep2024 ₹5 Cr
54.24
Jun2024 ₹3 Cr
-40.09
Mar2024 ₹6 Cr -
Operating Margins
Q-o-Q

-14.64 %

Y-o-Y

-37.21 %

Quarters Operating Margin% % Change
Dec2025 9.33%
-14.64
Sep2025 10.93%
1.96
Jun2025 10.72%
Positive
Mar2025 -5.43%
Negative
Dec2024 14.86%
25.08
Sep2024 11.88%
48.50
Jun2024 8%
-34.21
Mar2024 12.16% -

MEDICAMEN BIOTECH Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-22.70 %

Y-o-Y

-44.05 %

Quarters Profit After Tax % Change
Dec2025 ₹2 Cr
-22.70
Sep2025 ₹2 Cr
32.02
Jun2025 ₹2 Cr
-14.06
Mar2025 ₹2 Cr
-36.21
Dec2024 ₹3 Cr
222.87
Sep2024 ₹1 Cr
13.41
Jun2024 ₹1 Cr
-60.92
Mar2024 ₹2 Cr -
PAT Margins
Q-o-Q

-22.10 %

Y-o-Y

-46.06 %

Quarters PAT Margin(%) % Change
Dec2025 3.49 %
-22.10
Sep2025 4.48 %
20.43
Jun2025 3.72 %
-40.86
Mar2025 6.29 %
-2.78
Dec2024 6.47 %
220.30
Sep2024 2.02 %
9.19
Jun2024 1.85 %
-57.18
Mar2024 4.32 % -

MEDICAMEN BIOTECH Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-18.27 %

Y-o-Y

-41.03 %

Quarters EPS % Change
Dec2025 ₹1.61
-18.27
Sep2025 ₹1.97
23.90
Jun2025 ₹1.59
-16.32
Mar2025 ₹1.9
-30.40
Dec2024 ₹2.73
137.39
Sep2024 ₹1.15
8.49
Jun2024 ₹1.06
-36.53
Mar2024 ₹1.67 -

You may also like the below Video Courses